European Market Open Indices mixed amid strong possibility of no deal Brexit
- The FTSE 100 is called to open higher this morning after ending yesterday’s session at its highest level since early March. European indices are called to open lower, with the DAX and the CAC set to build on the losses they have seen this week.
- UK Boris Johnson has warned there is a ‘strong possibility’ of a no-deal Brexit as negotiations continue until Sunday.
- For stocks, UK regulators have given banks the green light to resume dividend payments, Calisen recommends a £1.4 billion takeover, and the vaccine being developed by GSK and Sanofi is hit by a setback.
- Brent has pushed through the $50 mark for the first time since early March, when the coronavirus pandemic caused demand to plummet, as markets hope the roll-out of vaccines will push up demand going forward.
No-deal Brexit a ‘strong possibility’
Hopes that a last-minute Brexit deal will be agreed are waning as UK prime minister Boris Johnson warned there is a ‘strong possibility’ of a no-deal Brexit as negotiators continue to try and deliver material progress by Sunday. Meanwhile, the EU has also started to propose no-deal contingency measures, starting with ones to keep planes and haulage trucks flowing over the Channel.
The two sides remain far apart on three major sticking points – fisheries, governance and maintaining a level playing field.
Fresh stimulus for the EU
EU leaders have agreed on a new EUR1.8 trillion package to help the bloc bounce back from the coronavirus crisis. The first day of the European Council summit has been productive after Hungary and Poland, which had previously opposed the budget, were convinced to drop their objections.
That came on the same day the European Central Bank launched new stimulus to help the eurozone recover. While the central bank left interest rates alone, it did raise its bond-buying programme and introduced new liquidity for banks.
European indices to open slightly lower
The Euro STOXX Index is called to open marginally lower at 3415.5 from its closing price on Thursday of 3517.4.
Germany’s DAX is set to open lower at 13271.0 from 13286.7 at yesterday’s close, while France’s CAC 40 is called to open at 5536.4 compared to 5542.3. Both indices have lost ground this week, with the DAX down 0.1% and the CAC having shed 1.3%.
Find out more about trading indices here.
FTSE 100 called higher after closing at new high
The FTSE 100 is set to gain further ground today and is called to open 0.1% higher at 6603.8 from 6597.2 at the close on Thursday – when it ended the day at its highest level since early March. The index is up 0.7% over the week so far.
Top stock news
The top news from European stocks this morning is:
UK regulator gives banks green light to resume dividends
UK regulators have given the green light for banks to resume dividend payments after asking them to suspend payouts and preserve cash when the coronavirus crisis rocked global markets earlier this year. The Prudential Regulation Authority said ‘banks are resilient to a wide range of economic outcomes, including economic scenarios that are materially more severe than current central expectations.’ The regulator added that ‘there is scope for banks to recommence some distributions should their boards choose to do so, within an appropriately prudent framework.’
Rolls Royce to return to positive cashflow in late 2021
Rolls Royce said its expectations remain unchanged as its business continues to be hard-hit by the coronavirus pandemic. The company recently completed a large rights issue to shore up its balance sheet and said on Friday that it expects to return to positive cashflow ‘at some point during the second-half of 2021’.
Calisen recommends £1.4 billion takeover
Smart energy meter company Calisen, which only listed at the start of the year, said it is recommending a £1.4 billion takeover offer for the company. It said the offer is worth 261 pence per share in cash, a premium to the current share price and above its IPO price of 240p.
GlaxoSmithKline and Sanofi vaccine hit by setback
Sanofi has revealed development of a coronavirus vaccine with GSK has been hit by a setback. The latest data shows the vaccine prompted the desired immune response from younger people but that response in older adults was not as good as hoped. As a result, the pair intend to launch a Phase 2a study in February, representing a major delay considering a Phase 3 study was due to be launched by the end of the year.
Novartis secures EU approval for cholesterol drug
Novartis said it has secured approval from the EU for Leqvio, a drug that helps lower cholesterol. The Swiss pharmaceutical firm purchased the drug last year for $9.4 billion and expects it to be what is known as a blockbuster drug.
Zurich Insurance to buy MetLife for almost $4 billion
Zurich Insurance has revealed its subsidiary has agreed to buy the property and casualty business of US outfit MetLife for $3.94 billion.
Banco BPM reported to be considering merger
Reuters reports this morning that Italian outfits Banco BPM and BPER Banca are considering a merger during the first half of 2021. The move comes after Banco BPM failed to break ground during initial talks about a deal with UniCredit.
Louis Camilleri quits Ferrari and Philip Morris
Louis Camilleri has quit as the chief executive of Ferrari after two and half years in the job. The company’s chairman John Elkann will take over in the interim period. Camilleri has also separately said it will quit his role as executive chairman of tobacco giant Philip Morris.
Forex: Dollar falls as yen strengthens
City Index analyst Tony Sycamore writes this morning about how Brexit continues to weigh on GBP/USD.
The most drastic movements in the currency markets this morning, according to data from Reuters, are as follows:
FX Pair | Price | Net Change |
---|---|---|
USD/JPY | 104 | -0.20% |
USD/INR | 73.554 | -0.19% |
USD/BRL | 5.0256 | -0.14% |
GBP/JPY | 138.56 | -0.05% |
EUR/JPY | 126.48 | -0.03% |
Commodities: Oil prices break through $50 mark
The progress being made with the rollout of coronavirus vaccines, with the UK and Canada having approved their first ones and the US set to authorise one as early as this week, is giving markets confidence that demand for oil will increase going forward.
Brent trades at $50.29 this morning from $50.38 at Thursday’s close, when the benchmark breached the $50 mark for the first time since early March. WTI trades at $46.99 from $47.03 yesterday. Attention is on the Baker Hughes US oil rig count at 1800 GMT.
Find out more about trading the volatility in oil here.
Gold trades at $1836.0 per ounce this morning compared to $1836.7 at the close yesterday as the safe-haven continues to edge lower after hitting a two-week high on Monday.
Find out how to trade gold and other precious metals here.
Market-moving events in the economic calendar
The economic calendar is light today. In the UK, focus is on the Bank of England’s financial stability press conference at 0830 GMT, following on from the report being published at 0700 GMT. Attention turns to the US data in the afternoon.
You can view all the scheduled events for today using our economic calendar, and keep up to date with the latest market news and analysis here.
Time (GMT) |
Country |
Event |
0830 |
UK |
Bank of England Financial Stability Report Press Conference |
1330 |
US |
Producer Price Index Ex Food & Energy (Nov) |
1500 |
US |
Michigan Consumer Sentiment Index (Dec) |
StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.
No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
For further details see our full non-independent research disclaimer and quarterly summary.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.
City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.
City Index is a trademark of StoneX Financial Ltd.
The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.
© City Index 2024